Bipolar disorder comes in many distinct forms and genetic differences cause people to respond differently to lithium, paving ...

Matt Walz is the CEO of Trialbee, a global leader in technology-driven patient recruitment. He brings more than 20 years of software and leadership experience in the life sciences industry. Matt ...

UpToDate—the popular clinical research and information database used by thousands of hospitals around the globe—has ...

Gain perspective on how agentic AI can bridge eCOA, EDC, IRT, and CTMS platforms to reduce manual effort and improve ...

Discover groundbreaking eczema research with Sara J. Brown, exploring skin organoids, genetics, and future breakthroughs in ...

Oncology patients often undergo chemotherapy, which causes myelotoxicity and depletes blood, immune and clotting cells. They ...

Steve Rosenberg, CEO, uMotif, discusses the challenges sites face with eCOA, eConsent, and ePRO platforms and the support ...

Many drug trials are vetted by companies with ties to the drugmakers, raising concerns about conflicts of interest and ...

Dr. Alexander Spira explained the difference between a clinical trial and a real-world study in a CURE interview for patients with lung cancer. Real-world studies represent an important step in the ...

A groundbreaking Genomic Press interview explores how Dr. Martin Alda transformed worldwide understanding of bipolar disorder ...

Scientists on Monday said initial trial results for Pfizer Inc and BioNTech's coronavirus vaccine far outpaced their expectations for protection against a completely new disease, but that many ...

Artificial intelligence tools are now used in a variety of different ways in Michigan Medicine’s emergency department, from helping physicians give feedback to detecting patients at higher risk for ...